A recent study on 1746 cancer patients has shown that those with lower subcutaneous fat, ie fat under the skin, have increased mortality and shorter survival rates than those with higher subcutaneous fat, especially in those who suffered from sarcopenia (reduced muscle mass due to cancer).
A moderate level of subcutaneous fat has also been shown to protect from cardiovascular disease, not just cancer (the "obesity paradox").
This study has shown that, as with cardiovascular disease, it is not overall fat that counts the most, but subcutaneous fat in particular. In contrast, visceral (stomach) fat increases the risk of heart disease, and according to this study it does not play a significant role in cancer.
Subcutaneous adiposity is an independent predictor of mortality in cancer patients
Georgios Tzenichristos is the director of London's London-based LipoTherapeia clinic, which specialises in natural fat/cellulite reduction and skin tightening. Georgios daily follows all research on fat, metabolism, connective tissue and phytochemicals and regularly writes about those topics. To check all our recent articles visit lipotherapeia.com/metabolism.
You may republish (as is or amended) this specific article in your blog or other publication without permission from us, provided that you kindly link back to this page or to lipotherapeia.com. The copyright remains with LipoTherapeia Ltd.